Rankings
▼
Calendar
PRGO Q1 2022 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
Q1 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.1B
+6.4% YoY
Gross Profit
$338M
31.4% margin
Operating Income
$22M
2.0% margin
Net Income
-$2M
-0.2% margin
EPS (Diluted)
$-0.01
QoQ Revenue Growth
-2.8%
Cash Flow
Operating Cash Flow
$79M
Free Cash Flow
$59M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$10.4B
Total Liabilities
$5.3B
Stockholders' Equity
$5.1B
Cash & Equivalents
$2.0B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.1B
$1.0B
+6.4%
Gross Profit
$338M
$368M
-8.3%
Operating Income
$22M
$51M
-57.8%
Net Income
-$2M
$38M
-106.3%
Revenue Segments
Consumer Self-Care Americas
$710M
66%
Consumer Self-Care International
$365M
34%
Geographic Segments
UNITED STATES
$683M
63%
Europe
$352M
33%
Other Geographical Areas
$40M
4%
IRELAND
$7M
1%
← FY 2022
All Quarters
Q2 2022 →